🇺🇸 FDA
Patent

US 11096954

Bisphosphocin gel formulations and uses thereof

granted A61KA61K31/7072A61K47/10

Quick answer

US patent 11096954 (Bisphosphocin gel formulations and uses thereof) held by Lakewood Amedex, Inc. expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lakewood Amedex, Inc.
Grant date
Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/7072, A61K47/10, A61K47/34, A61K9/0014